Çagla Tükel, PhD, Associate Professor of Microbiology and Immunology at the Lewis Katz School of Medicine at Temple University, was the senior author on a new study published online in the journal Nature Communications that showed a first-of-its-kind therapeutic molecule, a type of monoclonal antibody, shows promise as an immunotherapeutic strategy to break apart communities of harmful bacteria known as biofilms and open the way for antibiotics. These biofilms are notorious for forming on implanted medical devices and on tissues in the body, where they give rise to chronic and sometimes life-threatening infections in patients. Multiple media outlets, including Bioengineer.org, Scienmag, News-Medical.net and ScienceDaily, reported on the findings.
Weather Alert: A major winter storm is likely to impact the Philadelphia region this weekend into Monday. Temple Health remains open, though some appointments or services may be adjusted. Patients will be contacted directly if their visit is affected. Please check TempleHealth.org for updates and monitor myTempleHealth for changes to scheduled appointments.
800-TEMPLE-MED
Schedule Appointment
SEARCH TEMPLE HEALTH